Skip to main content
Binu John, MD, Gastroenterology, Miami, FL

BinuJohnMDMPH

Gastroenterology Miami, FL

Hepatology & Liver Transplantation

Chief of Hepatology, Miami VA Medical Center, Miami FL

Dr. John is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. John's full profile

Already have an account?

  • Office

    1201 16th St nw
    Miami, FL 33125
    Phone+1 305-575-7000

Summary

  • Dr. Binu John is a gastroenterologist and hepatologist in Miami, FL. He specializes in hepatology & liver transplantation, is an Affiliate Associate Professor, University of Miami Miller School of Medicine and Chief of Hepatology at the Bruce W Carters VA Medical Center. He is experienced in hepatology, transplant hepatology, portal hypertension, and hepatocellular carcinoma.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Gastroenterology, 2007 - 2010
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2005 - 2007
  • Christian Medical College Vellore
    Christian Medical College VelloreClass of 1998

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2013 - 2025
  • VA State Medical License
    VA State Medical License 2016 - 2022
  • OH State Medical License
    OH State Medical License 2005 - 2018
  • American Board of Internal Medicine Gastroenterology
  • American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Publications & Presentations

PubMed

Press Mentions

  • Third COVID-19 Vaccine Dose Reduces Infection, Critical Disease Risk in Cirrhosis by 80%
    Third COVID-19 Vaccine Dose Reduces Infection, Critical Disease Risk in Cirrhosis by 80%November 7th, 2022
  • Third Dose of COVID-19 Vaccine Offers Needed Boost in Protection for Cirrhosis Patients
    Third Dose of COVID-19 Vaccine Offers Needed Boost in Protection for Cirrhosis PatientsOctober 26th, 2022
  • Miller School Faculty Front and Center at DDW ’22
    Miller School Faculty Front and Center at DDW ’22June 28th, 2022
  • Join now to see all

Professional Memberships